Suppression of B cell lymphomagenesis by the BH3-only proteins Bmf and Bad

由 Frenzel, Anna, Labi, Verena, Chmelewskij, Waldemar, Ploner, Christian, Geley, Stephan, Fiegl, Heidelinde, Tzankov, Alexandar, Villunger, Andreas
出版 2009

Clinical Impact of RANK Signalling in Ovarian Cancer

由 Wieser, Verena, Sprung, Susanne, Tsibulak, Irina, Haybaeck, Johannes, Hackl, Hubert, Fiegl, Heidelinde, Marth, Christian, Zeimet, Alain Gustave
發表在 Cancers (Basel) (2019)

Association of TNFRSF10D DNA-Methylation with the Survival of Melanoma Patients

由 Ratzinger, Gudrun, Mitteregger, Simone, Wolf, Barbara, Berger, Regina, Zelger, Bernhard, Weinlich, Georg, Fritsch, Peter, Goebel, Georg, Fiegl, Heidelinde
出版 2014

Tumor necrosis factor receptor modulator spermatogenesis‐associated protein 2 is a novel predictor of outcome in ovarian cancer

由 Wieser, Verena, Tsibulak, Irina, Degasper, Christine, Welponer, Hannah, Leitner, Katharina, Parson, Walther, Zeimet, Alain G., Marth, Christian, Fiegl, Heidelinde
發表在 Cancer Sci (2019)

Application of interferon modulators to overcome partial resistance of human ovarian cancers to VSV-GP oncolytic viral therapy

由 Dold, Catherine, Rodriguez Urbiola, Carles, Wollmann, Guido, Egerer, Lisa, Muik, Alexander, Bellmann, Lydia, Fiegl, Heidelinde, Marth, Christian, Kimpel, Janine, von Laer, Dorothee
發表在 Mol Ther Oncolytics (2016)

BRCA1/2 and TP53 mutation status associates with PD-1 and PD-L1 expression in ovarian cancer

由 Wieser, Verena, Gaugg, Inge, Fleischer, Martina, Shivalingaiah, Giridhar, Wenzel, Soeren, Sprung, Susanne, Lax, Sigurd F., Zeimet, Alain G., Fiegl, Heidelinde, Marth, Christian
發表在 Oncotarget (2018)

BRCA1 and BRCA2 mRNA-expression prove to be of clinical impact in ovarian cancer

由 Tsibulak, Irina, Wieser, Verena, Degasper, Christine, Shivalingaiah, Giridhar, Wenzel, Sören, Sprung, Susanne, Lax, Sigurd F., Marth, Christian, Fiegl, Heidelinde, Zeimet, Alain G.
發表在 Br J Cancer (2018)

The miR-34 family and its clinical significance in ovarian cancer

由 Welponer, Hannah, Tsibulak, Irina, Wieser, Verena, Degasper, Christine, Shivalingaiah, Giridhar, Wenzel, Sören, Sprung, Susanne, Marth, Christian, Hackl, Hubert, Fiegl, Heidelinde, Zeimet, Alain G.
發表在 J Cancer (2020)

The mitochondrial enzyme FAHD1 regulates complex II activity in breast cancer cells and is indispensable for basal BT‐20 cells in vitro

由 Holzknecht, Max, Guerrero‐Navarro, Lena, Petit, Michele, Albertini, Eva, Damisch, Elisabeth, Simonini, Anna, Schmitt, Fernando, Parson, Walther, Fiegl, Heidelinde, Weiss, Alexander, Jansen‐Duerr, Pidder
發表在 FEBS Lett (2022)

KCNJ3 is a new independent prognostic marker for estrogen receptor positive breast cancer patients

由 Kammerer, Sarah, Sokolowski, Armin, Hackl, Hubert, Platzer, Dieter, Jahn, Stephan Wenzel, El-Heliebi, Amin, Schwarzenbacher, Daniela, Stiegelbauer, Verena, Pichler, Martin, Rezania, Simin, Fiegl, Heidelinde, Peintinger, Florentia, Regitnig, Peter, Hoefler, Gerald, Schreibmayer, Wolfgang, Bauernhofer, Thomas
發表在 Oncotarget (2016)

Polymorphisms in the Gene Regions of the Adaptor Complex LAMTOR2/LAMTOR3 and Their Association with Breast Cancer Risk

由 De Araujo, Mariana E., Erhart, Gertraud, Buck, Katharina, Müller-Holzner, Elisabeth, Hubalek, Michael, Fiegl, Heidelinde, Campa, Daniele, Canzian, Federico, Eilber, Ursula, Chang-Claude, Jenny, Coassin, Stefan, Haun, Margot, Kedenko, Lyudmyla, Paulweber, Bernhard, Reitsamer, Roland, Himmel, Irmgard, Flesch-Janys, Dieter, Lamina, Claudia, Kronenberg, Florian, Huber, Lukas A., Kloss-Brandstätter, Anita
出版 2013